Factors Associated with High Blood Pressure in People Living with HIV at the National Teaching Hospital Hubert Koutoukou Maga and Cotonou Teaching Hospital of the Armed Forces
In Benin Republic, few data are available on the prevalence and determinants of arterial hypertension (AH) in people living with the human immunodeficiency virus (PLWHA). The present study was conducted in two outpatient treatment centers for PLWHA in Cotonou and was conducted from June 19 to July 04, 2019 with 314 PLWHA. We performed descriptive statistics and logistic regression for the estimates. The prevalence of high blood pressure (HBP) among PLWHA was 41.4% [CI (95%): (35.9 - 47)]. In univariate analysis: age, smoking, alcoholism, physical inactivity, family history of hypertension, personal history of diabetes, obesity, and total and LDL (low density lipoprotein) hypercholesterolemia were significantly associated with HBP. No association was found with duration of HIV (human immunodeficiency virus) infection, time to ARV (antiretrovirals) exposure, and treatment regimen. In multivariate analysis, age, sex, smoking, family history of hypertension, and total hypercholesterolemia remained associated with HBP. In conclusion, the prevalence of HBP in PLWHA was very high compared with the results in the general population, and the same risk factors described in the general population were found but with a more marked hypertense potential.
References
[1]
The New Humanitarian (2003) Une brève histoire d’antirétroviraux. Johannersburg. https://www.thenewhumanitarian.org/fr/report/42444/afrique-une-br%C3%A8ve-histoire-d%E2%80%99anti%C3%A9troviraux
[2]
Zannou, D., Tchabi, Y., Ahomadégbé, C., Akakpo, J., Azon Kouanou, A., Adè, G., et al. (2013) Risque cardiovasculaire chez les personnes vivant avec le VIH à l’hopital universitaire de Cotonou, Bénin. Médecine d’Afrique Noire, 60, 419-426.
[3]
Aubry, P.P. and Gausere, D.B.-A. (2019) Infection par le VIH/Sida et tropiques. Centre René Labusquière, Institut de Médecine Tropicale, Université de Bordeaux, Bordeaux, 20 p. http://medecinetropicale.free.fr/sida_tropical.pdf
[4]
Bognounou, R., Diendéré, A., Diallo, I., Tieno, H., Guira, O., Ouedraogo, D.D., et al. (2011) Metabolic Disorders and Cardiovascular Risk Factors Observed in Patients Infected by the HIV with Antiretroviral Therapy in Burkina Faso. Tropical Medicine, 71, 626-627.
[5]
Houngbe, C. (2013) Prévalence de l’insuffisance rénale et facteurs associés chez les patients traités par les antirétroviraux au CNHU-HKM. Thèse de Médecine No. 1632, Faculté des sciences se santé de Cotonou, Cotonou.
[6]
Zannou, D.M. and Gansou, N. (2014) Les dyslipidémies: Prévalence et facteurs associés chez les sujets infectés au VIH à l’hôpital universitaire Hubert K. MAGA de Cotonou. Faculté de Sciences de la Santé (FSS) de Cotonou/Université d’Abomey-Calavi (UAC), Cotonou.
[7]
Earnshaw, V.A., Lang, S.M., Lippitt, M., Jin, H. ans Chaudoir, S.R. (2015) HIV Stigma and Physical Health Symptoms: Do Social Support, Adaptive Coping, and/or Identity Centrality Act as Resilience Resources? AIDS and Behavior, 19, 41-49. https://doi.org/10.1007/s10461-014-0758-3
[8]
Zannou, D.M. and Fatindé, N. (2017) Evaluation a long terme du traitement antirétroviral deuxième ligne dans un centre de référence à Cotonou. Faculté de Sciences de la Santé (FSS) de Cotonou/Université d’Abomey-Calavi (UAC), Cotonou.
[9]
World Health Organization (2015) Rapport final de l’enquête pour la surveillance des facteurs de risque des maladies non transmissibles par l’approche ‘’STEPSwise’’ de l’OMS ENQUETE ‘’STEPS 2015’’ au Bénin.pdf. https://www.who.int/ncds/surveillance/steps/Benin_2015_STEPS_Report_FR.pdf
[10]
Adébayo, A., Albert, D.C., Ericie, S., Angelo, A.C., Jules, G., Armand, W., et al. (2015) Prévalence, facteurs associés et prédisposant au syndrome métabolique chez les personnes vivants avec le VIH sous traitement antirétroviral à Porto-Novo en 2014. Pan African Medical Journal, 22, Article No. 296. https://doi.org/10.11604/pamj.2015.22.296.7923 https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4769044/
[11]
National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III) (2002) Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III) Final Report. Circulation, 106, 3143-3421. https://doi.org/10.1161/circ.106.25.3143
[12]
Magalhães, M.G., Greenberg, B., Hansen, H. and Glick, M. (2007) Comorbidities in Older Patients with HIV: A Retrospective Study. Journal of the American Dental Association, 138, 1468-1475. https://doi.org/10.14219/jada.archive.2007.0083
[13]
Menanga, A.P., Ngomseu, C.K., Jingi, A.M., Mfangam, B.M., Noubiap, J.J.N., Gweth, M.N., et al. (2015) Patterns of Cardiovascular Disease in a Group of HIV-Infected Adults in Yaoundé, Cameroon. Cardiovascular Diagnosis and Therapy, 5, 420-427. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4666691/
[14]
Dimala, C.A., Atashili, J., Mbuagbaw, J.C., Wilfred, A. and Monekosso, G.L. (2016) Prevalence of Hypertension in HIV/AIDS Patients on Highly Active Antiretroviral Therapy (HAART) Compared with HAART-Naïve Patients at the Limbe Regional Hospital, Cameroon. PLoS ONE, 11, Article ID: e0148100. https://doi.org/10.1371/journal.pone.0148100 https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4749660/
[15]
Benzekri, N.A., Seydi, M., Doye, I.N., Toure, M., Sy, M.P., Kiviat, N.B., et al. (2018) Increasing Prevalence of Hypertension among HIV-Positive and Negative Adults in Senegal, West Africa, 1994-2015. PLoS ONE, 13, Article ID: e0208635. https://doi.org/10.1371/journal.pone.0208635 https://journals.plos.org/plosone/article?id=10.1371/journal.pone.0208635
[16]
Gazzaruso, C., Bruno, R., Garzaniti, A., Giordanetti, S., Fratino, P., Sacchi, P., et al. (2003) Hypertension among HIV Patients: Prevalence and Relationships to Insulin Resistance and Metabolic Syndrome. Journal of Hypertension, 21, 1377-1382. https://doi.org/10.1097/00004872-200307000-00028 https://journals.lww.com/jhypertension/Abstract/2003/07000/Hypertension_among_HIV_patients___prevalence_and.28.aspx
[17]
Bergersen, B., Sandvik, L., Dunlop, O., Birkeland, K. and Bruun, J. (2003) Prevalence of Hypertension in HIV-Positive Patients on Highly Active Retroviral Therapy (HAART) Compared with HAART-Naive and HIV-Negative Controls: Results from a Norwegian Study of 721 Patients. European Journal of Clinical Microbiology and Infectious Diseases, 22, 731-736. https://doi.org/10.1007/s10096-003-1034-z
[18]
Houinato, D.S., Gbary, A.R., Houehanou, Y.C., Djrolo, F., Amoussou, M., Segnon-Agueh, J., et al. (2012) Prevalence of Hypertension and Associated Risk Factors in Benin. Revue d’épidémiologie et de Santé Publique, 60, 95-102. https://doi.org/10.1016/j.respe.2011.09.010
[19]
DANEL, C.H.H. and Guehi, C.H.H. (2017) Facteurs de risque cardiovasculaire chez les patients avant et après initiation des antirétroviraux en Afrique Sub-Saharienne, expérience de l’Essai Temprano ANRS 12 136. Université de Bordeaux, Bordeaux. http://www.theses.fr/2016BORD0324
[20]
Houetondji, H.L.C., Alassani, A., Sonou, D.A., Dohou, S.H., Awassi, B., Adjagba, P.M., et al. (2018) Prévalence de l’hypertension artérielle chez les diabétiques de type 2 suivis en milieu hospitalier à Parakou en 2016. Médecine d’Afrique Noire, 65, 49-58. https://bec.uac.bj/uploads/publication/7d8e002336fca4407caa9c13702eb83a.pdf
[21]
da Cunha, G.H., Lima, M.A.C., Galvão, M.T.G., Fechine, F.V., Fontenele, M.S.M. andSiqueira, L.R. (2018) Prevalence of Arterial Hypertension and Risk Factors among People with Acquired Immunodeficiency Syndrome. Revista Latino-Americana de Enfermagem, 26, Article No. e3066. https://doi.org/10.1590/1518-8345.2684.3066
[22]
Hoseinean, R. (2012) élucider la complexité de la fatigue liée au VIH. Nouvelles CATIE. https://www.catie.ca/fr/nouvellescatie/2012-10-23/elucider-complexite-fatigue-liee-vih
[23]
Signorini, D.J.H.P., Monteiro, M.C.M., Andrade, M.deF.C.de, Signorini, D.H. and Eyer-Silva, W.de.A. (2012) What Should We Know about Metabolic Syndrome and Lipodystrophy in AIDS? Revista da Associação Médica Brasileira, 58, 70-75.
[24]
Rogalska-Plońska, M., Grzeszczuk, A., Rogalski, P., Lucejko, M. and Flisiak, R. (2018) Metabolic Syndrome in HIV Infected Adults in Poland. Kardiologia Polska, 76, 548-553. https://doi.org/10.5603/KP.a2017.0249 https://ojs.kardiologiapolska.pl/kp/article/view/11666
[25]
Arruda, L.M., Oliveira, J.M., Cotta Rmm, D.E. and Ribeiro, S.M.R. (2015) Perfil Sociossanitário DE Portadores DE Hipertensão Arterial Cadastrados NA Estratégia DE Saúde DA Família, Divinésia, Minas Gerais. Arquivos, 18. https://periodicos.ufjf.br/index.php/aps/article/view/15402
[26]
Kiama, C.N., Wamicwe, J.N., Oyugi, E.O., Obonyo, M.O., Mungai, J.G., Roka, Z.G., et al. (2018) Prevalence and Factors Associated with Metabolic Syndrome in an Urban Population of Adults Living with HIV in Nairobi, Kenya. Pan African Medical Journal, 29, Article No. 90. https://doi.org/10.11604/pamj.2018.29.90.13328 https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5987082/
[27]
Malaza, A., Mossong, J., Bärnighausen, T. and Newell, M.-L. (2012) Hypertension and Obesity in Adults Living in a High HIV Prevalence Rural Area in South Africa. PLoS ONE, 7, Article ID: e47761. https://doi.org/10.1371/journal.pone.0047761 https://www.journals.plos.org/plosone/article?id=10.1371/journal.pone.0047761
[28]
de la Serna, J.I.B., Zamora, F.X., Montes, M.L., García-Puig, J. and Arribas, J.R. (2010) Hipertensión arterial, infección por el virus de la inmunodeficiencia humana y tratamiento antirretrovírico de gran actividad. Enfermedades Infecciosas y Microbiología Clínica, 28, 32-37. https://doi.org/10.1016/j.eimc.2008.07.005
[29]
Baekken, M., Os, I., Sandvik, L. and Oektedalen, O. (2008) Hypertension in an Urban HIV-Positive Population Compared with the General Population: Influence of Combination Antiretroviral Therapy. Journal of Hypertension, 26, 2126-2133. https://doi.org/10.1097/HJH.0b013e32830ef5fb
